Climb Bio, Inc.
CLYM
$7.01
-$0.12-1.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.52M | -12.89M | -8.67M | -20.78M | -8.42M |
| Total Depreciation and Amortization | 30.00K | 29.00K | 38.00K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 584.00K | 3.51M | 491.00K | 1.42M | 1.22M |
| Change in Net Operating Assets | 1.27M | -2.79M | -3.01M | 3.93M | 1.67M |
| Cash from Operations | -15.64M | -12.14M | -11.15M | -15.43M | -5.52M |
| Capital Expenditure | 0.00 | -109.00K | -77.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.54M | 15.37M | 4.86M | -42.75M | -53.41M |
| Cash from Investing | 25.54M | 15.26M | 4.79M | -42.75M | -53.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 65.00K | -- | -- | -- | 291.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -86.00K | -- | -- | -- | -250.00K |
| Cash from Financing | -21.00K | -- | -- | -- | 41.00K |
| Foreign Exchange rate Adjustments | -- | -- | 24.00K | -24.00K | -57.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.88M | 3.12M | -6.34M | -58.21M | -58.95M |